India Equity Analyst - Fundamental & Thematic, Beat the Street

Sudarshan Bhandari

India Equity Analyst - Fundamental & Thematic

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Equity Bottom-Up

<ul>
<li>Kopran Limited has approved the merger of its diagnostics arm, Kopran Laboratories, aiming to become a fully integrated pharmaceutical and healthcare solutions provider. </li>
<li>The merger diversifies Kopran’s revenue mix, enhances EBITDA margins with high-value consumables, and unlocks synergies across pharma and diagnostics distribution channels. </li>
<li>Kopran transitions from a mid-scale exporter to a multi-vertical healthcare platform, with stronger earnings visibility, improved capital efficiency, and potential for valuation re-rating.</li>
</ul>


Kopran Limited has approved the merger of its diagnostics arm, Kopran Laboratories, aiming to become a fully integrated pharmaceutical and healthcare solutions provider. 
The merger diversifies Kopran’s revenue mix, enhances EBITDA margins with high-value consumables, and unlocks synergies across pharma and diagnostics distribution channels. 
Kopran transitions from a mid-scale exporter to a multi-vertical healthcare platform, with stronger earnings visibility, improved capital efficiency, and potential for valuation re-rating.


The Kopran Merger: From APIs to Diagnostics, A Blueprint for Healthcare Integration

India

Oricon Enterprises Ltd. has interests in Real Estate, Marine Logistics, Packaging, Petrochemicals and Automobile Dealerships in India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Oricon Enterprises (OTE IN)

The Kopran Merger: From APIs to Diagnostics, A Blueprint for Healthcare Integration

Kopran Limited merges diagnostics arm to become fully integrated pharmaceutical and healthcare solutions provider, diversifying revenue mix and...

Sudarshan Bhandari

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

The Kopran Merger: From APIs to Diagnostics, A Blueprint for Healthcare Integration

​Kopran Limited merges diagnostics arm to become fully integrated pharmaceutical and healthcare solutions provider, diversifying revenue mix and...

Sudarshan Bhandari

Kopran Limited merges diagnostics arm to become fully integrated pharmaceutical and healthcare solutions provider, diversifying revenue mix and...